BioCentury
ARTICLE | Company News

Broadvector, Vectura deal

February 27, 2012 8:00 AM UTC

Vectura's Innovata Ltd. subsidiary granted Broadvector rights to IP covering a prodrug therapy for hip implant failure due to aseptic loosening. The therapy consists of an injection of an adenovirus s...